X0407 4 2023-06-08 0 0001531177 Sight Sciences, Inc. SGHT 0001870875 Encrantz Staffan C/O SIGHT SCIENCES, INC. 4040 CAMPBELL AVE., SUITE 100 MENLO PARK CA 94025 1 0 1 0 0 Common Stock 2023-06-08 4 A 0 11940 0.00 A 11940 D Common Stock 2023-06-08 4 A 0 15094 0.00 A 11940 D Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on June 8, 2022 under the Issuer's Non-Employee Director Compensation Program, as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on August 5, 2022. Each RSU represented a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs vested in full on June 8, 2023. Reflects a grant of RSUs made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of Common Stock. The number of RSUs granted is equal to approximately $120,000 of shares of Common Stock as determined by the closing price on the grant date, June 8, 2023. The RSUs vest on the earlier of June 8, 2024 and the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. /s/ Jeremy Hayden, Attorney-in-Fact for Staffan Encrantz 2023-06-12